These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


161 related items for PubMed ID: 37051708

  • 1. Gestational and Postpartum Complications in Patients with First Trimester Thyrotoxicosis: A Prospective Multicenter Cohort Study from Northeast China.
    Xu Y, Li C, Wang W, Yu X, Liu A, Shi Y, Xie X, Li J, Li Y, Shan Z, Teng W, Li Y.
    Thyroid; 2023 Jun; 33(6):762-770. PubMed ID: 37051708
    [Abstract] [Full Text] [Related]

  • 2. The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease.
    Tagami T, Hagiwara H, Kimura T, Usui T, Shimatsu A, Naruse M.
    Thyroid; 2007 Aug; 17(8):767-72. PubMed ID: 17651013
    [Abstract] [Full Text] [Related]

  • 3. [Effect of the treatment acceptance on the perinatal outcomes in women with subclinical hypothyroidism, positive thyroid gland peroxidase antibody in early pregnancy].
    Yang J, Guo H, Ding S, Tao B, Zhang X.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Sep; 50(9):652-7. PubMed ID: 26675390
    [Abstract] [Full Text] [Related]

  • 4. Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?
    Yoshihara A, Noh JY, Mukasa K, Suzuki M, Ohye H, Matsumoto M, Kunii Y, Watanabe N, Suzuki N, Kameda T, Sugino K, Ito K.
    Endocr J; 2015 Sep; 62(6):557-60. PubMed ID: 25819223
    [Abstract] [Full Text] [Related]

  • 5. Pitfalls in the assessment of gestational transient thyrotoxicosis.
    Iijima S.
    Gynecol Endocrinol; 2020 Aug; 36(8):662-667. PubMed ID: 32301638
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of the effect of different diagnostic criteria of subclinical hypothyroidism and positive TPO-Ab on pregnancy outcomes].
    He Y, He T, Wang Y, Xu Z, Xu Y, Wu Y, Ji J, Mi Y.
    Zhonghua Fu Chan Ke Za Zhi; 2014 Nov; 49(11):824-8. PubMed ID: 25603906
    [Abstract] [Full Text] [Related]

  • 7. [A clinical study on gestational transient thyrotoxicosis].
    Wen BH, Teng WP, Shan ZY, Li YB, Li J, Gao B, Shang T, Zhou JR, Li CY, Zhou WW, Ding B, Ma Y, Wu Y, Liu Q, Liu W, Yu XH, Chen YY, Wang WW, Fan CL, Wang H, Guo R.
    Zhonghua Nei Ke Za Zhi; 2008 Dec; 47(12):1003-7. PubMed ID: 19134305
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of gestational thyrotoxicosis in Asian women evaluated in the 8th to 14th weeks of pregnancy: correlations with total and free beta human chorionic gonadotrophin.
    Yeo CP, Khoo DH, Eng PH, Tan HK, Yo SL, Jacob E.
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):391-8. PubMed ID: 11589683
    [Abstract] [Full Text] [Related]

  • 9. MANAGEMENT OF THYROTOXICOSIS: PRECONCEPTION, PREGNANCY, AND THE POSTPARTUM PERIOD.
    Pearce EN.
    Endocr Pract; 2019 Jan; 25(1):62-68. PubMed ID: 30289300
    [Abstract] [Full Text] [Related]

  • 10. Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow.
    Ide A, Amino N, Kang S, Yoshioka W, Kudo T, Nishihara E, Ito M, Nakamura H, Miyauchi A.
    Thyroid; 2014 Jun; 24(6):1027-31. PubMed ID: 24400892
    [Abstract] [Full Text] [Related]

  • 11. Congenital thyrotoxicosis in premature infants.
    Smith C, Thomsett M, Choong C, Rodda C, McIntyre HD, Cotterill AM.
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):371-6. PubMed ID: 11298090
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
    Scappaticcio L, Trimboli P, Keller F, Imperiali M, Piccardo A, Giovanella L.
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
    [Abstract] [Full Text] [Related]

  • 13. Relationship between gestational transient thyrotoxicosis and vitamin D.
    Küçükler FK, Şimşek Y, Görkem Ü, Ayçiçek Doğan B, Güler S.
    Turk J Med Sci; 2016 Nov 17; 46(5):1374-1378. PubMed ID: 27966300
    [Abstract] [Full Text] [Related]

  • 14. The association between dyslipidaemia in the first trimester and adverse pregnancy outcomes in pregnant women with subclinical hypothyroidism: a cohort study.
    Wang X, Zhang E, Tian Z, Zhao R, Huang K, Gao S, Su S, Xie S, Liu J, Luan Y, Zhang Y, Zhang Z, Yan Y, Yue W, Yin C, Liu R.
    Lipids Health Dis; 2024 Jan 11; 23(1):13. PubMed ID: 38212787
    [Abstract] [Full Text] [Related]

  • 15. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease.
    Amino N, Tanizawa O, Mori H, Iwatani Y, Yamada T, Kurachi K, Kumahara Y, Miyai K.
    J Clin Endocrinol Metab; 1982 Jul 11; 55(1):108-12. PubMed ID: 6896207
    [Abstract] [Full Text] [Related]

  • 16. Perinatal effects of maternal FT3/FT4 ratio on gestational transient thyrotoxicosis.
    Gürkan E, Dolapçıoğlu K, Dirican E.
    Arch Endocrinol Metab; 2021 Nov 03; 65(4):450-454. PubMed ID: 34283898
    [Abstract] [Full Text] [Related]

  • 17. Partial prediction of postpartum Graves' thyrotoxicosis by sensitive bioassay for thyroid-stimulating antibody measured in early pregnancy.
    Ide A, Amino N, Nishihara E, Kudo T, Ito M, Kimura Y, Tatsumi N, Yamazaki M, Miyauchi A.
    Endocr J; 2016 Oct 29; 63(10):929-932. PubMed ID: 27432817
    [Abstract] [Full Text] [Related]

  • 18. Incidence of and Risk Factors for Neonatal Hypothyroidism Among Women with Graves' Disease Treated with Antithyroid Drugs Until Delivery.
    Yoshihara A, Noh JY, Inoue K, Watanabe N, Fukushita M, Matsumoto M, Suzuki N, Suzuki A, Kinoshita A, Yoshimura R, Aida A, Imai H, Hiruma S, Sugino K, Ito K.
    Thyroid; 2023 Mar 29; 33(3):373-379. PubMed ID: 36680759
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.